Electroconvulsive therapy for depression: 80 years of progress.

depression electroconvulsive therapy evidence-based medicine meta-analysis treatment resistance

Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
11 2021
Historique:
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 14 4 2022
Statut: ppublish

Résumé

Electroconvulsive therapy is the most effective treatment for severe, psychotic or treatment-resistant depression. However, its effectiveness continues to be questioned, both in mainstream media and narratives within the scientific literature. In this analysis, we use an evidence-based approach to demonstrate the efficacy and safety of modern electroconvulsive therapy.

Identifiants

pubmed: 35048827
doi: 10.1192/bjp.2021.37
pii: S0007125021000374
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

594-597

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom

Auteurs

George Kirov (G)

MRC Centre for Neuropsychiatric Genetics & Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Sameer Jauhar (S)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Pascal Sienaert (P)

Academic Center for ECT and Neuromodulation, University Psychiatric Center, KU Leuven, Belgium.

Charles H Kellner (CH)

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, South Carolina, USA.

Declan M McLoughlin (DM)

Department of Psychiatry and Trinity College Institute of Neuroscience, Trinity College Dublin, St Patrick's University Hospital, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH